Viewing Study NCT02128334


Ignite Creation Date: 2025-12-25 @ 2:37 AM
Ignite Modification Date: 2026-02-20 @ 4:46 PM
Study NCT ID: NCT02128334
Status: COMPLETED
Last Update Posted: 2016-08-16
First Post: 2014-04-29
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: An Observational Study Looking at How Well the Drug Eligard Works and How Well it is Tolerated by the Body of Patients With Advanced Prostate Carcinoma in the Russian Federation
Sponsor: Astellas Pharma Europe B.V.
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Advanced Prostate Carcinoma View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Uro-Oncologists View
None PSA View
None Eligard View
None prostate carcinoma View